SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E)— 510(k) K252463

Name: FDA 510(k) clearance K252463
Creator: U.S. Food and Drug Administration
Published: 2026-07-02

Substantially Equivalent

Edan Instruments, Inc.

FDA 510(k) clearance K252463 for SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E), Substantially Equivalent on 2026-07-02. Applicant: Edan Instruments, Inc.. Device class: 2.

Clearance details

Applicant: Edan Instruments, Inc.
Product code: Code DPS
Device class: Class 2
Regulation: 21 CFR 870.2340
Advisory panel: Cardiovascular
Date received: 2025-08-06
Decision date: 2026-07-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Shenzhen, CN

Download summary PDF View on FDA.gov ↗

Recent devices under product code DPS

view all

K251670 — MAC 7 Resting ECG Analysis System2026-01-26
K252361 — AccurECG Analysis System (v2.0)2025-12-22
K252474 — Withings BeamO (SCT02)2025-11-10
K250569 — Cardiologs Holter Platform2025-08-06
K243252 — ZBPro Diagnostic2025-07-10

More clearances from Edan Instruments, Inc.

view all

K251508 — Telemetry Monitor (iT30, iT50)2026-08-06
K251591 — Holter ECG and ABP system (HolterABP)2026-02-09
K251268 — Diagnostic Ultrasound System (Nano C5, Nano C5 EXP, Nano L12, and Nano L12 EXP)2025-12-23
K241882 — Fetal & Maternal Monitor (F15A, F15A Air)2025-08-27
K250179 — Patient Monitor (CX10, CX12, CX15, UX10, UX12, UX15)2025-07-29

Adverse events under product code DPS

product code DPS

Death: 7
Total: 7

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.